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Friend murine leukemia virus (F-MuLV,  l  Friend helper virus) is unusual in 
that it causes different types of hematopoietic neoplasms in different strains of 
mice. BALB/c mice develop erythroblastosis 2 to 3 mo after neonatal inoculation 
with F-MuLV (1, 2). C57BL/6 mice are resistant to erythroblastosis but develop 
lymphoma or myelogenous leukemia --5 months after neonatal inoculation (2, 
3). Resistance to erythroblastosis in this system is not due to interference with F- 
MuLV  replication  (2).  We  previously  showed  that  the  C57BL/6  resistance 
appears to be controlled by a single dominant gene in first and second backcrosses 
to BALB/c (2). 
Recombinant inbred (RI) strains (4) provide an alternative to standard Men- 
delian crosses for genetic analysis of population traits such as median latency for 
development of disease or tendency to develop one disease rather than another. 
RI  strains are  families of inbred mice derived by inbreeding different sets of 
progeny from a cross between two parental strains. Because of inbreeding, mice 
of a given RI strain are genetically identical and homozygous at essentially every 
locus. For traits controlled by a single gene, each RI strain will resemble one or 
the other parental strain depending on which parental allele it carries at that 
locus. One can use RI strains to map new single gene traits by typing each strain 
for the  new trait and  comparing inheritance of alleles at the  new  locus with 
inheritance of alleles at other loci for which the RI lines have been typed. RI 
lines can also be used to determine whether a  particular trait is controlled by 
more than one gene. For such traits, individual RI lines may resemble neither 
parent strain due to inheritance of combinations of alleles at different loci that 
do not occur together in either parental strain. 
We have characterized the seven RI lines derived from a cross between BALB/ 
c and C57BL/6 for latency and type of disease induced by F-MuLV. The results 
show that resistance to F-MuLV erythroblastosis is inherited independently of 
previously identified Friend virus resistance genes, and also independently of 
genes that control latency. 
Materials and Methods 
Mice.  BALB/cAnn, C57BL/6N, C57BL/10 (B10), NFS/N, and outbred NIH Swiss 
mice were  obtained from NIIt,  Small Animals Section.  BALB/cAnnHSD  mice were 
Abbreviations used in this paper: F-MuLV, Friend murine leukemia virus; MCF, mink cell focus- 
forming; RI, recombinant  inbred; SFFV, spleen focus-forming  virus. 
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obtained from Harlan Sprague Dawley, Inc. (Indianapolis, IN) and BALB/cTr mice from 
Dr. Michael Potter, NIH. From The Jackson Laboratory (Bar Harbor, ME) we obtained 
BALB/cJ, C57BL/6J, BALB/cBy, C57BL/6By, and the seven RI lines CXB-D, CXB-E, 
CXB-G, CXB-H, CXB-I, CXB-J, and CXB-K. These mice were bred in our laboratory. 
Progeny were inoculated intraperitoneally at 0-2 d of age and then transferred to NIH 
Swiss, NFS/N,  or BALB/c mothers for foster nursing.  The age at  which babies were 
inoculated (0,  1,  or 2 d) and the strain of foster mother had no discernible effect on 
latency or type of disease  induced by F-MuLV.  NFS.E  s° mice, kindly provided by Dr. 
Wallace Rowe, NIH, are partially congenic for the somber coat color (E~°), a dominant 
allele at the recessive yellow locus. 
Virus.  NB-tropic F-MuLV was a kind gift from Dr. Janet w. Hartley, NIH. This virus 
was  derived by endpoint dilution of a  pool of anemia-inducing Friend virus complex 
originally obtained from Dr. Charlotte Friend and forced-passaged for several years in 
BALB/c mice. Virus pools used in these experiments came from the tenth and eleventh 
passages  in NFS/N mouse embryo cells after cloning in the same cells. 
Hematopathology.  Mice were palpated weekly for enlarged spleen or lymph nodes and 
sacrificed when obviously sick.  Diagnoses  were based on  gross pathology, hematocrit, 
Wright-Giemsa strains of peripheral blood, spleen and lymph node "touch" preps, and 
hematoxylin-eosin stained sections of fixed tissues.  Diagnostic criteria have been discussed 
(2). Mice were followed until sick or for a minimum of 200 d after inoculation. 
Blot H~,bridization.  DNA  was  obtained  from  mouse  spleens as  described (5).  After 
restriction  with  XbaI,  DNAs  were  electrophoresed  in  0.6%  agarose,  transferred  to 
nitrocellulose by the method of Southern (6), and hybridized to a ~2P-labeled ecotropic 
virus-specific probe (5) as described (7). 
Statistics.  Disease  incidence in  different strains  was compared using chi square (x  2) 
with Yates correction (8). Disease-free survival curves were constructed (9) and compared 
by the log rank test (9). 
Results 
Susceptibility to F-MuL V Ervthroblastosis Among the CXB-RI Strains.  BALB/c mice 
of all substrains  tested including BALB/cBy, one parent of the CXB-RI strains, 
are highly susceptible to F-MuLV erythroblastosis (Table 1). In contrast, C57BL/ 
6  mice of several substrains,  including C57BL/6By are highly resistant  to ery- 
throblastosis.  Of the seven CXB-RI strains,  only CXB-H is highly susceptible to 
erythroblastosis (Table I). 
The pattern of inheritance of susceptibility to erythroblastosis among the RI 
lines is distinct from the pattern of inheritance of BALB/c alleles at H-2, Gpd-1 
(closely  linked  to  Fv-1  [10]),  Fv-2,  Rfv-3,  and  Cv,  the  BALB/c  endogenous 
ecotropic virus (Table II). This confirms previous experiments (2) which showed 
that  resistance  to  F-MuLV  erythroblastosis  is  not  linked  to H-2,  Gpd-1,  Mod-I 
(linked to Fv-2),  and Hm (linked to Cv) in the first backcross to BALB/c. Thus, 
none  of  these  genes  is  the  major  determinant  of  susceptibility  to  F-MuLV 
erythroblastosis. In contrast, there is complete concordance between inheritance 
of By,  the  endogenous  ecotropic  virus  of C57BL/6  mice,  and  resistance  to 
erythroblastosis (Table II). This provocative result raised the possibility that By 
or a closely linked gene was responsible for resistance to erythroblastosis. Because 
the  number  of RI  lines  tested  was  small,  and  concordant  inheritance  in  this 
number of RI strains implies about a  40% chance of linkage (11), we proceeded 
to test backcross mice for association between By and resistance to erythroblas- 
tosis. 
Susceptibility to F-MuLV Ervthroblastosis in  Crosses Segregating Bv.  Two experi- SILVER  AND  FREDRICKSON  1695 
TABLE  I 
Type of Hematopoietic Disease Induced by F-MuLV 
Number inoc-  Mouse strain  ulated 
Percent of mice developing indicated dis- 
ease * 
Erythroblasto-  Lymphoma  Myeloid leu- 
sis  kemia 
BALB/c (various substrains*)  55  87  4  2 
BALB/cBy  11  82  0  0 
C57BL/6 (various substrains l)  52  0  46  27 
C57BL/6By  30  0  60  17 
CXB-D  29  7  62  17 
CXB-E  29  4  48  10 
CXB-G  34  3  53  38 
CXB-H  42  79  12  14 
CXB-I  21  0  71  10 
CXB-J  39  3  64  18 
CXB-K  33  15  45  15 
* Occasional mice were judged to have two neoplasms; e.g., one CXB-H mouse had erythroblastosis 
plus thymic lymphoma and two CXB-H mice had thymic lymphoma plus myeloid leukemia. Mice 
not developing the indicated disease (~ 17% of the total) died of other diseases or undetermined 
causes. The most common nonhematopoietic disease was pneumonia, which accounted for 9% of 
all deaths. Because some mice had two hematopoietic diseases and others none, the percentages for 
a given mouse strain may add up to more or less than 100%. 
* 20 BALB/cAnn, 20 BALB/cAnnHSD, 15 BALB/cr. 
23 C57BL/6N, 29 C57BL/6J. 
TABLE  II 
Inheritance of Virus-related Genes* Among the CXB-RI Strains 
(Fv-  1  )  (Rmcf)  Susceptibility to 
Strain  H-2  Gpd-1  Fv-2  Rfv-3  Cv  Bv  F-MuLV ery- 
throblastosis 
CXB-D  C  C  C  --  B  B  B 
CXB-E  B  C  C  B  C  B  B 
CXB-G  B  C  C  C  B  B  B 
CXB-H  C  B  B  --  C  C  C 
CXB-I  B  C  B  --  C  B  B 
CXB-J  B  B  C  C  C  B  B 
CXB-K  B  B  C  B  C  B  B 
* c  indicates inheritance of the BALB/c allele or phenotype, and B inheritance of the 
C57BL/6 allele or phenotype. Data for H-2, Gpd-1, and Fv-2  are from (4), Rfv-3 from 
(17), Cv and Bv from (26), and susceptibility to F-MuLV erythroblastosis  from this 
paper, Table I. 
ments  were  done  to  test  for  linkage  between  Bv  and  resistance  to  F-MuLV 
erythroblastosis. In the first experiment we tested BALB/c ×  (BALB/c x  C57BL/ 
6)  and  BALB/c  X  (BALB/c  x  B10.D2)  mice  for  inheritance of Bv  by  blot 
hybridization. The Cv and Bv endogenous ecotropic viruses can be distinguished 
by the  size of the  left-hand flanking sequence when genomic DNA  is cut with 
Xba I and probed with an ecotropic virus specific probe (12). DNA was extracted 
from the leukemic spleens of 20 mice inoculated with F-MuLV as neonates.  10 
of these  mice  had  erythroblastosis,  while  10  had  lymphoma  or  myelogenous 
leukemia.  If Bv  or  a  closely  linked  gene  determined  resistance  to  F-MuLV 1696  FRIEND  HELPER  VIRUS  LEUKEMIAS  IN  CXB-RI  MICE 
erythroblastosis, one would expect backcross mice with lymphoma or myeloge- 
nous leukemia to have inherited Bv, while backcross mice with erythroblastosis 
should not have inherited Bv.  As shown in Table IIIA, no correlation was seen 
between type of leukemia and inheritance of Bv. 
A representative Southern blot from these experiments is shown in Fig.  1. In 
addition to the major bands corresponding to Bv and Cv, faint bands can be seen 
in the range of 2.5  to  10 kiiobases in the tumor but not in the control DNAs. 
These extra bands are presumably due to multiple F-MuLV integrations. Such 
discrete bands imply that the F-MuLV leukemias are clonal or oligoclonal. The 
faintness of the minor bands compared with those of Bv and Cv may be due to 
the presence of nonleukemic cells in the spleens of these mice, to oligoclonality 
TABLE  III 
Resistance to F-MuLV Erythroblastosis  Is Not Controlled  by By 
A.  Absence of linkage to By in BALB/c x  (BALB/c x  C57BL) mice.* 
Number of mice with: 
By*  Erythroblastosis  Lymphoma or myeloid 
leukemia 
+  4  4 
-  6  6 
B.  Absence of linkage to E "° (somber) in BALB/c x  [B10 x  (NFS.E  ~° x 
B10)]  mice. 
Number of mice/total inoculated 
Predicted by  Erythro-  Lymphoma or mye- 
Coat color  genotype  blastosis  loid leukemia 
Agouti  +/-  1  / 14  9/14 
Somber  -/-  1  / 10  6/10 
* X2 =  0.2, p >  0.6. 
* Presence of Bv determined by blot hybridization (see text). 
FIGURE  1.  Blot hybridization ofXba I cut genomic DNA from normal and F-MuLV leukemic 
C57BL/6,  BALB/c and  BALB/c x  (BALB/c x  C57BL/6)  mice probed  with an  ecotropic 
virus-specific probe.  Lanes  1 and  12, size markers with size in kilobases indicated on the left. 
Lane 2, normal C57BL/6By liver DNA. Lane 3, normal BALB/cBy liver DNA. Lanes 4-11, 
DNA from spleens of leukemic BALB/c x  (BALB/c X C57BL/6) mice with: lymphoma (lanes 
4,  5,  9,  and  10),  erythroblastosis (lanes  6,  8,  and  11)  and  myelogenous  leukemia (lane  7). 
Backcross mice in lanes 6 and 8 inherit By. SILVER  AND  FREDRICKSON  1697 
of the tumors, or to weaker hybridization of the probe to F-MuLV compared 
with endogenous ecotropic viruses. 
In a  second experiment to test for linkage between Bv and resistance to F- 
MuLV erythroblastosis, we  made use of the dominant coat color  marker E ~° 
(somber),  which  is  closely linked to Bv  (13).  BALB/c females were  mated to 
hybrid  males  that  carried  E ~°  on  one  chromosome  8  and  Bv  on  the  other 
chromosome 8 (genotype of males: B 10 x  (NFS.E  ~° × B 10)). The progeny of this 
cross were inoculated with F-MuLV as neonates. If Bv or a closely linked gene 
caused resistance to  FoMuLV erythroblastosis, the agouti  offspring would be 
expected to be resistant to erythroblastosis and the somber offspring, susceptible. 
As shown in Table III B, no difference was observed between somber and agouti 
offspring. We conclude from this and the previous experiment that resistance to 
F-MuLV erythroblastosis and Bv are inherited independently. 
Almost all of the BALB/c ×  [B10  ×  (NFS.E  ~° ×  B10)]  mice were resistant to 
erythroblastosis (Table IIIB). This result suggests that the first backcross fathers 
used in this cross were homozygous for a dominant resistance gene from B 10. 
Minor Gene Effects on the Type of Leukemia Induced by F-MuLV.  While C57BL/ 
6 mice are strongly resistant to F-MuLV erythroblastosis (no cases in 82 inocu- 
100 
90, 
80 
w 
~0  70.  .( 
uJ 
a 
u.  60,  0 
w 
w 
n- 
50' 
40, 
30, 
~ .  ..,.~  ,,  ~'..  ",. 
•  ..  •  , 
•  :  •  . 
~",°,  o  ~  *'°** 
~  °°° 
~  .  "°°% 
~  '.  °o.° 
~  ".  °°'.°..°°.°°°o 
C  HJ  G  DBK  I  E 
I  I  I  I  I  I  I  I  l  i 
25  50  75  100  125  150  175  200  225  250 
DAY  AFTER  INOCULATION 
FIGURE 2.  Disease-free survival for C57BL/6 (B), BALB/c (C), and CXB-RI mice (D, E, G, 
H, L J, and K) inoculated with F-MuLV as neonates. The ordinate gives the percent of mice 
free of hematopoietic neoplasm (erythroblastosis, lymphoma, and myelogenous leukemia) as a 
function of" time after inoculation. The mice used to construct this figure are the same as those 
described in Table 1. Survival differences between BALB/c and CXB-H and between CXB-J 
and C57BL/6 are statistically significant (p <0.01 and p <0.025, respectively, log rank test). 1698  FRIEND  HELPER  VIRUS  LEUKEM1AS  IN  CXB-RI  MICE 
lated mice), some of the CXB-R! lines show incomplete resistance (Table I). For 
example, 5 cases of erythroblastosis were seen among 33 CXB-K mice. Compared 
with C57BL/6  mice, this  15% incidence of erythroblastosis is highly significant 
(x  2 =  9.9, p  <  0.005).  This suggests that minor genes modify the strength of 
resistance to F-MuLV erythroblastosis. 
The proportion of cases of myelogenous leukemia varied among the erythro- 
blastosis-resistant  strains,  being  highest in  CXB-G,  intermediate in  C57BL/6, 
and lowest in CXB-I and CXB-E mice (Table I).  While these data suggest that 
different combinations of parental  alleles  may affect relative  susceptibility  to 
myeloid vs. lymphoid leukemia, the differences between strains are not statisti- 
cally significant (heterogeneity X  2 =  10.85, df =  6, p >  0.10). 
Latent Period for F-MuLV Leukemias in  the CXB-RI Strains.  Because C57BL/6 
mice develop disease from F-MuLV, on the average, several months later than 
BALB/c  mice,  it  could  be  argued  that  the  type  of hematopoietic  neoplasm 
induced by F-MuLV is a function of the age of the mouse when transformation 
occurs.  The  RI  strains  permit  a  test  of this  hypothesis.  Disease-free survival 
curves for BALB/c, C57BL/6  and the seven RI  strains fall into three groups 
(Fig. 2). BALB/c mice have the shortest disease-free survival with 50% incidence 
by 85 d. Most of the RI strains are similar to C57BL/6, with median survival of 
145-175 d. Two of the RI strains, CXB-H and CXB-J, have intermediate survival 
with  median incidence of disease at  110-120  d.  The survival of CXB-H  and 
CXB-J mice is statistically significantly different from that of either parent strain 
(see legend to Fig. 2), indicating that more than one gene affects latency. 
The two strains with intermediate latency succumb to different diseases. -~80% 
of CXB-H  mice develop erythroblastosis while >80%  of CXB-J  mice develop 
lymphoma or myelogenous leukemia (Table I). Since disease-free survival curves 
for these strains are essentially identical, age at onset is not the primary deter- 
minant of type of leukemia induced by F-MuLV. 
Discussion 
The data presented here confirm and extend previous reports that suscepti- 
bility to  F-MuLV  erythroblastosis is  controlled by different genes  than  those 
which affect susceptibility to  Friend complex disease.  The latter disease is an 
acute erythroblastosis induced by spleen focus-forming virus (SFFV), a  replica- 
tion-defective virus that requires a replication-competent "helper" virus in order 
to spread and cause disease in vivo (14).  Analysis of mouse strains resistant to 
Friend complex (SFFV)  disease  led  to  the  identification of genes  that  affect 
replication of the helper virus (Fv-I  [15],  Fv-4 [16]), host immune response to 
virus (Rfv-3 [ 17], H-2 [ 18], H-2-1inked genes Rfv-1 and Rfv-2 [ 19]), and replication 
of  SFFV  (Fv-2  [20]).  Since  genes  restricting  replication  of  F-MuLV  would 
presumably interfere with development of F-MuLV erythroblastosis, the mice 
and virus used in these experiments were chosen to be permissive at Fv-I  and 
Fv-4. 
Genes affecting host immune resPonse to  Friend helper virus might be ex- 
pected to influence response to F-MuLV erythroblastosis. However, alleles at H- 
2 and Rfv-3 did not correlate with susceptibility to F-MuLV erythroblastosis in 
CXB-RI strains. The lack of 1-1-2 effect was also seen in congenic BALB.B and SILVER  AND  FREDRICKSON  1699 
B 10.D2 mice (2). The absence of effect of H-2 or Rfv-3 in these experiments may 
be due to the fact that  virus inoculation of newborn mice obviates an immune 
response. 
A  particularly  interesting  result is that Fv-2 does not control susceptibility to 
F-MuLV erythroblastosis, as indicated by the fact that CXB-H mice (Fv-2  rr) are 
susceptible to F-MuLV erythroblastosis. This result is consistent with a previous 
observation that C58 mice, also Fv-U  r, are susceptible to F-MuLV erythroblastosis 
(21). The difference in genetic control of SFFV disease vs. F-MuLV erythroblas- 
tosis  suggests  that  these  diseases  are  biologically  distinct.  This  conclusion  is 
strengthened by the observation that SFFV causes polycythemia or mild anemia 
with  reticuiocytosis (22),  whereas  F-MuLV erythroblastosis is characterized  by 
severe anemia  with  reticulocytopenia  (2),  implying a  more profound block to 
terminal differentiation of erythrocytes in the latter disease. 
The  lack  of concordance  between inheritance  of Cv and  susceptibility to  F- 
MuLV erythroblastosis  is  important  because it  indicates  lack of association  of 
resistance with a newly described gene, Rm~  which is very closely linked to Cv 
(23). Rmcfcontrols replication of mink cell focus-forming (MCF) viruses in vitro 
(23) and appears to be responsible for at least part of the resistance of DBA/2 
mice to F-MuLV erythroblastosis (J. Hartley and W. Rowe, unpublished results). 
The Rmcfallele carried by C57BL/6 does not restrict replication of MCF viruses 
in vitro (23). However, MCF viruses are not generated in C57BL mice inoculated 
with F-MuLV as neonates (reference 3, and J. Silver, unpublished observations). 
It was therefore important  to test whether C57BL mice carry a variant allele at 
Rmcf that  is responsible for resistance to F-MuLV erythroblastosis. The  lack of 
correlation with Cv in the RI strains argues against this possibility and is consistent 
with our previous observation that resistance is not linked to Hm, a morphological 
marker that maps to the same region of chromosome 5 as Cv and Rm¢(2). 
The C57BL resistance could be due to non-Rmcf-mediated interference with 
the generation of MCF viruses, or to restriction of erythroblastosis-specific MCF 
viruses. Experiments are in progress to test for a correlation between the presence 
of MCF viruses and  type of disease induced  by F-MuLV in  F1  and  backcross 
mice, and to see whether MCF viruses generated by F-MuLV in  BALB/c mice 
can replicate and cause erythroblastosis in C57BL mice. 
Previous experiments suggested that one major C57BL gene, designated Fhe  ~, 
controls resistance to F-MuLV erythroblastosis in first and second backcrosses to 
BALB/c (2).  It is tempting to propose that the 6  RI strains that are resistant to 
F-MuLV erythroblastosis carry the Fhe  ~ allele. However, these RI lines could be 
resistant because of recessive resistance genes. Therefore, correlations between 
the current results and backcross data must await further tests of the dominance 
of resistance in the CXB-RI lines. 
The  resistance of some of the  RI lines  is incomplete compared with C57BL 
mice.  Similarly,  the  resistance  of BALB/c  x  (B10  x  (NS.E  s°  x  B10))  mice  is 
incomplete compared  with  (BALB/c  x  C57BL)F~  mice  These  results  indicate 
that more than one gene affects the strength  of resistance to F-MuLV erythro- 
blastosis. 
CXB-J  and  CXB-H  provide  an  instructive  pair  of strains  in  that  they  have 
essentially identical disease-free survival after inoculation with F-MuLV, yet one 1700  FRIEND HELPER VIRUS LEUKEMIAS IN  CXB-RI MICE 
strain  develops  predominantly  erythroblastosis  while  the  other  succumbs  to 
lymphoma and myelogenous leukemia. This result indicates that the tendency to 
develop erythroblastosis rather than iymphoma or myelogenous leukemia is not 
simply a function of age of onset of disease. 
The study of mouse genes that affect the type of leukemia induced by F-MuLV 
may complement studies of virus genes that  affect the target cell for transfor- 
mation.  Recent experiments  indicate  that  replacing  the  U3 region  of the  long 
terminal repeat of Friend virus with the homologous region from Moloney virus, 
changes the disease induced in NFS/N mice from erythroblastosis to lymphoma 
(24). Similarly, changes in the U3 region of viruses isolated from BALB/c mice 
account  for  differences  in  tissue  tropism  and  leukemogenicity  (25).  It  will 
therefore be of great interest to look for differences in the U3 region of MCF 
viruses  generated  by  F-MuLV  in  strains  of  mice  susceptible  or  resistant  to 
erythroblastosis. 
Summary 
The seven CXB recombinant  inbred  strains  were tested for susceptibility to 
Friend helper virus (F-MuLV) hematopoietic neoplasms.  BALB/c and  CXB-H 
mice  develop erythroblastosis  after  neonatal  inoculation  with  F-MuLV,  while 
C57BL/6  and  the  six  other  RI  strains  develop  lymphoma  and  myelogenous 
leukemia.  This strain  distribution pattern  is different from that for H-2, Gpd-1 
(linked to Fv-l), Fv-2, Rfv-3, and Cv (linked to Rmcf) but the same as that for Bv, 
the endogenous ecotropic virus of C57BL/6.  However, analysis of crosses seg- 
regating Bv show that resistance to F-MuLV erythroblastosis is not linked to Bv. 
Disease-free survival is shortest for BALB/c mice, intermediate  for CXB-H and 
CXB-J, and longest for C57BL/6 and the other RI strains. We conclude: (a) the 
major C57BL/6 gene for resistance to F-MuLV erythroblastosis is different from 
previously identified Friend virus restriction loci; (b) latency for F-MuLV leuke- 
mias is controlled by more than one gene; and (c) latency and susceptibility to F- 
MuLV erythroblastosis are not inherited concordantly in the CXB-RI strains. 
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